AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SUTRO BIOPHARMA, INC. Director's Dealing 2021

Jan 27, 2021

34319_dirs_2021-01-27_c99c47c3-adf1-46ff-ade9-f1ecd29d5437.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SUTRO BIOPHARMA, INC. (STRO)
CIK: 0001382101
Period of Report: 2021-01-26

Reporting Person: Petree Daniel H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-26	Common Stock	M	4132	$4.36	Acquired	7988	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-26	Stock Option (right to buy Common Stock)	$4.36	M	4132	Disposed	2021-02-08	Common Stock (4132)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	192	Indirect

Footnotes

F1: These securities are held of record by the reporting person and his spouse as trustees of the Daniel H. Petree and Susan M. Toeniskoetter Trust dated July 25, 1997.

F2: The option is fully vested and exercisable.